Aptevo Therapeutics Inc. (APVO) › Total LiabilitiesAptevo Therapeutics Inc. (APVO) — Total LiabilitiesAnnual figures by fiscal year, from SEC filings.2015: $39.15M2016: $41.29M2017: $34.97M2018: $37.09M2019: $41.57M2020: $36.95M2021: $55.38M2022: $16.24M2023: $12.62M2024: $10.84M2025: $9.81M$9.81M2015Total Liabilities (USD)2025Fiscal YearTotal LiabilitiesChange YoY2025$9.81M-9.4%2024$10.84M-14.1%2023$12.62M-22.3%2022$16.24M-70.7%2021$55.38M+49.9%2020$36.95M-11.1%2019$41.57M+12.1%2018$37.09M+6.1%2017$34.97M-15.3%2016$41.29M+5.5%2015$39.15M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share